Clinical Trial

Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-25.
Trial Details
NCT Number NCT06196515
Lead Sponsor British University In Egypt
Conditions Endodontic Disease, Pulp Disease, Dental
Enrollment 54 participants
Start Date 2024-08
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-19